Pine Labs Stock Surges as Global Brokersions Bullish on Fintech Growth; UBS, Citi Set High Price Targets

Pine Labs Stock Surges as Global Brokersions Bullish on Fintech Growth; UBS, Citi Set High Price Targets​

Shares of Pine Labs Ltd experienced a significant rally on Wednesday, surging over 4 percent following positive reassessments from major brokerage houses. Analysts cited strong growth prospects across payments processing, merchant solutions, and affordability products, driving the stock higher in trading.

##Brokerage Reiterates Bullish Callbacks on Fintech Growth

Pine Labs rose 4.3 percent during the session to Rs 156.6 after initial gains were trimmed. The momentum comes as UBS and Citi reaffirmed their "buy" ratings, signaling confidence in the company's expansive growth trajectory.

UBS maintained its "buy" rating with a target price of Rs 220, suggesting a potential upside exceeding 44 percent from current levels. Similarly, Citi retained its "buy" call, setting a target of Rs 235, which implies a 54 percent potential rise based on existing valuations.

##Key Growth Drivers Across Payments and Affordability

The brokerage firms emphasized that Pine Labs' multi-pronged growth strategy is paving the way for substantial future expansion. UBS highlighted the company's affordability business, noting that Gross Merchandise Value (GMV) is projected to reach Rs 740 billion in FY26, marking a 22 percent year-on-year increase.

UBS also pointed out Pine Labs' strategic move into EMI-on-UPI offerings. This initiative is seen as vital for preserving profitability as consumer transactions increasingly shift toward the UPI ecosystem.

##Enterprise Focus and Market Expansion Strategy

During the analyst interaction, management disclosed robust momentum within its online payments vertical. The company successfully secured more than 25 large enterprise deals and currently commands approximately 5 percent market share in online payments, a figure expected to increase over time.

UBS detailed that Pine Labs is strategically expanding its core subscription business by targeting medium-sized enterprises. Furthermore, the firm is widening its point-of-sale (PoS) offerings across government sectors and oil marketing companies.

##Financial Projections and Profitability Outlook

Both international brokerages painted a highly positive picture of financial health and expansion. UBS noted that management maintained guidance for over 20 percent revenue growth alongside margin expansion. The brokerage anticipates Pine Labs' revenue to grow at a compound annual rate (CAGR) of 19 percent between FY26 and FY28.

Citi agreed on the improving monetization environment within B2B fintech, noting opportunities for Pine Labs to increase attach rates across its merchant, banking, and brand partnerships. Citi projects that adjusted EBITDA margins will expand significantly, reaching 26 percent in FY27 and 30 percent by FY28.

##Analyst Views on Long-Term Trajectory

Emkay Global Financial Services also maintained a "buy" rating with a target price of Rs 225 for the stock. The brokerage projects that Pine Labs' revenue will grow at a CAGR of 20.3 percent from FY26 to FY28, while EBITDA is expected to expand dramatically at a CAGR of 41.8% over the same period.

Management highlighted several key growth vectors beyond current offerings, including affordability solutions, employee benefits, gaming ventures, and strategic expansion into the US market. The company stated that operating leverage would increasingly support profitability as the business continues to scale.

##Broader Market Context

The domestic market saw a positive session on Wednesday, providing a supportive backdrop for the fintech stock surge. At 11:03 am, the Sensex was up 296.54 points, or 0.39 percent, trading at 77,105.02. Meanwhile, the Nifty experienced an upward trend, rising 85.80 points, or 0.36 percent, closing at 24,074.95.